| Catalog Number |
20089006 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Subcutaneous Nodule (4548)
|
| Date of Event |
02/19/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Healthcare professional (hcp) reported performing ¿a gold needle treatment on a patient, and after the healing period¿ which was one and half month later, the patient was injected with skinvive¿ by juvéderm®.There were no issues after the first treatment; the patient's skin quality significantly improved and there was a noticeable reduction in wrinkles.Sometime later, the patient received a second treatment of skinvive¿ by juvéderm® and after this ¿second application, nodules formed under the skin.¿ despite attempting dissolution procedures, the desired result was not achieved.Symptoms are ongoing.This record captured the 1st injection.
|
| |
|
Additional Manufacturer Narrative
|
|
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.This is a known potential adverse event addressed in the product labeling.
|
| |
|
Additional Manufacturer Narrative
|
|
A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.Additional, changed, and/or corrected data: a2, a3a, b3, b5, c1, d4, d6a, h4, h6, h8.
|
| |
|
Event or Problem Description
|
|
The hcp additionally reported injecting a patient with 1ml of skinvive¿ by juvéderm® in the ¿right side¿ of the face.One month later, the patient was injected with 2ml of skinvive¿ by juvéderm® on both sides of the face.Approximately one month later, the patient went in for examination complaining of a nodule at the eye corners and cheeks.The patient was treated with hyaluronidase into the nodule.The dose was 5-15u per lesion.
|
| |
|
Search Alerts/Recalls
|